Legal Representation
Attorney
Gregory B. Phillips
USPTO Deadlines
Next Deadline
178 days remaining
NOA E-Mailed - SOU Required
Due Date
June 23, 2026
Extension Available
Until December 23, 2026
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 23, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 28, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 28, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 22, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 29, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 29, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 29, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 29, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 29, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 11, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 26, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 17, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Apr 17, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products targeting selected biological pathways, namely, for the treatment of autoimmune and neurodegenerative diseases and for use in organ and cellular transplantation
Additional Information
Design Mark
The mark consists of stylized letter "E" displayed backwards and adjacent to a stylized letter "P", with the word "ELEDON" above the word "PHARMACEUTICALS" to the right.
Pseudo Mark
E P ELEDON PHARMACEUTICALS
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"